Results 11 to 20 of about 13,630 (218)

Treatment of cryptococcal meningitis in KwaZulu-Natal, South Africa. [PDF]

PLoS ONE, 2010
Cryptococcal meningitis (CM) remains a leading cause of death for HIV-infected individuals in sub-Saharan Africa. Improved treatment strategies are needed if individuals are to benefit from the increasing availability of antiretroviral therapy.
Josephine V J Lightowler, Graham S Cooke, Portia Mutevedzi, Richard J Lessells, Marie-Louise Newell, Martin Dedicoat   +5 more
doaj   +3 more sources

Cryptococcal meningitis in India

MGM Journal of Medical Sciences, 2019
Cryptococcal meningitis caused by the environmental yeast Cryptococcus neoformans has emerged as a significant pathogen in immunocompromised and immunocompetent patient especially in human immunodeficiency virus (HIV) or acquired immune deficiency ...
Pushpa Yadav, Manodeep Sen, Anupam Das, Tanushri Chaterji   +3 more
doaj   +2 more sources

Experiences of diagnosis and treatment of 102 cases with cryptococcal meningitis and/or cryptococcal meningoencephalitis

Chinese Journal of Contemporary Neurology and Neurosurgery, 2014
Objective To summarize the clinical manifestations and diagnostic and therapeutic strategies of 102 cases with cryptococcal meningitis and/or cryptococcal meningoencephalitis, and to improve the diagnosis and treatment of cryptococcal meningitis ...
Yan-yu CHANG, Xue-qiang HU
doaj   +1 more source

Pulmonary Aspergillosis Treated With Oral Amphotericin B (MAT2203) in a Patient With HIV-Related Cryptococcal Meningitis. [PDF]

Clin Case Rep
Graphical abstract for a case of a 26‐year‐old female with advanced HIV disease, cryptococcal meningitis, and co‐infection with pulmonary aspergillosis. Both co‐infections were successfully treated with the novel oral lipid nanocrystal formulation of amphotericin B (MAT2203).
Kagimu E, Senkoro E, Gakuru J, Rutakingirwa MK, Boulware DR, Meya DB, Kwizera R.   +6 more
europepmc   +2 more sources

A prospective study of mortality from cryptococcal meningitis following treatment induction with 1200 mg oral fluconazole in Blantyre, Malawi. [PDF]

, 2014
OBJECTIVE: We have previously reported high ten-week mortality from cryptococcal meningitis in Malawian adults following treatment-induction with 800 mg oral fluconazole (57% [33/58]).
Allain, TJ, Rothe, Camilla, Jassi, Chikondi, Feasey, NA, Gnanadurai, Roshina, Feasey, Nicholas A, Lalloo David G., Goodson, P, Gaskell Katherine M., Harrison Thomas S., Rothe, C, Sloan, DJ, Goodson, Patrick, Katherine M Gaskell, Nicholas A Feasey, Lalloo, DG, Heyderman Robert S., Camilla Rothe, Lalloo, David G, Sloan Derek J., Gaskell, Katherine M, Sloan, Derek J, Jassi, C, Roshina Gnanadurai, Gaskell, KM, Jassi Chikondi, Harrison, Thomas S, Sloan, Derek J., Gaskell, Katherine M., Harrison, TS, Lalloo, David G., Harrison, Thomas S., Heyderman, Robert S, Goodson Patrick, Allain Theresa J., Thomas S Harrison, Chikondi Jassi, Derek J Sloan, David G Lalloo, Gnanadurai, R, Patrick Goodson, Rothe Camilla, Robert S Heyderman, Gnanadurai Roshina, Allain, Theresa J, Feasey Nicholas A., Allain, Theresa J., Theresa J Allain, Feasey, Nick; id_orcid, Heyderman, RS, Feasey, Nicholas A., Lalloo, David; id_orcid, Heyderman, Robert S.   +52 more
core   +1 more source

A Prospective Longitudinal Study of the Clinical Outcomes from Cryptococcal Meningitis following Treatment Induction with 800 mg Oral Fluconazole in Blantyre, Malawi [PDF]

, 2013
Introduction: Cryptococcal meningitis is the most common neurological infection in HIV infected patients in Sub Saharan Africa, where gold standard treatment with intravenous amphotericin B and 5 flucytosine is often unavailable or difficult to ...
Mavuto Mukaka, Rothe, Camilla, Feasey, NA, Tom Harrison, van Oosterhout Joep J., Denis, Brigitte, Lalloo David G., Goodson, P, Rothe, C, Jean Chikafa, Sloan, DJ, Goodson, Patrick, Nicholas A Feasey, Mukaka, Mavuto, Joep J van Oosterhout, Lalloo, DG, Allain, T, Heyderman Robert S., Camilla Rothe, Harrison, T, Sloan Derek J., Harrison, Tom, Harrison Tom, Sloan, Derek J., Allain Theresa, Mukaka, M, Lalloo, David G., Theresa Allain, Goodson Patrick, Denis, B, van Oosterhout, JJ, Chikafa, Jean, Derek J Sloan, David G Lalloo, Chikafa, J, Patrick Goodson, Brigitte Denis, Rothe Camilla, Robert S Heyderman, Feasey Nicholas A., Chikafa Jean, van Oosterhout, Joep J., Mukaka Mavuto, Allain, Theresa, Feasey, Nick; id_orcid, Heyderman, RS, Feasey, Nicholas A., Denis Brigitte, Lalloo, David; id_orcid, Heyderman, Robert S.   +49 more
core   +1 more source

Universal Screening of Tanzanian HIV-Infected Adult Inpatients with the Serum Cryptococcal Antigen to Improve Diagnosis and Reduce Mortality: An Operational Study. [PDF]

, 2011
Cryptococcal meningitis is a leading cause of death among HIV-infected individuals in sub-Saharan Africa. Recent developments include the availability of intravenous fluconazole, cryptococcal antigen assays and new data to support fluconazole pre-emptive
Fitzgerald, Daniel W, Wajanga, Bahati Mk, Samuel Kalluvya, Bahati MK Wajanga, Daniel W Fitzgerald, Peck, Robert N, Jennifer A Downs, Warren D Johnson, Downs, Jennifer A, Johnson, Warren D, Robert N Peck, Kalluvya, Samuel   +11 more
core   +1 more source

The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis. [PDF]

, 2013
BACKGROUND: Correlates of immune protection in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis are poorly defined.
Levitz, SM, Stone, Hunter H, Casazza, Joseph P, Richard A. Koup, Meintjes, Graeme, Levitz, Stuart M, Joseph P. Casazza, Joseph N. Jarvis, Stephen D. Lawn, Stuart M. Levitz, Harrison, Thomas S, Koup, RA, Lawn, Stephen D, Harrison, TS, Thomas S. Harrison, Koup, Richard A, Lawn, SD, Graeme Meintjes, Hunter H. Stone, Meintjes, G, Stone, HH, Jarvis, Joseph N, Jarvis, JN, Casazza, JP   +23 more
core   +1 more source

Poor long-term outcomes for cryptococcal meningitis in rural South Africa. [PDF]

, 2011
OBJECTIVES: To explore linkage to and retention in HIV care after an episode of cryptococcal meningitis (CM) in rural South Africa. Design. A retrospective case series of adult individuals (> or = 16 years old) with laboratory-confirmed CM from January -
Newell, Marie-Louise, Heller, T, Mutevedzi, PC, Heller, Tom, Lessells, Richard J, Newell, ML, Lessells, RJ, Mutevedzi, Portia C   +7 more
core   +1 more source

Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa. [PDF]

, 2013
OBJECTIVES: Cryptococcal meningitis (CM)-related mortality may be prevented by screening patients for sub-clinical cryptococcal antigenaemia (CRAG) at antiretroviral-therapy (ART) initiation and pre-emptively treating those testing positive.
Thomas S Harrison, Wood, R, Meintjes, Graeme, Joseph N. Jarvis, Joseph N. Jarvis (435279), Harrison Thomas S., Lawn, Stephen D, Cleary, Susan, Robin Wood, Joseph N Jarvis, Stephen D Lawn, Jarvis, JN, Jarvis Joseph N., Meintjes Graeme, Thomas S. Harrison (222993), Graeme Meintjes (221054), Stephen D. Lawn (116037), Robin Wood (4924), Lawn Stephen D., Susan Cleary, Susan Cleary (158497), Stephen D. Lawn, Harrison, Thomas S, Cleary, S, Wood Robin, Harrison, TS, Thomas S. Harrison, Cleary Susan, Lawn, SD, Graeme Meintjes, Meintjes, G, Jarvis, Joseph N, Wood, Robin   +32 more
core   +1 more source